Remove 2024 Remove Cholesterol Remove Lipid disorders
article thumbnail

Cholesterol’s Star Role in Dementia Prevention: New Insights from the 2024 Lancet Dementia Report 

Cardiometabolic Health Congress

The 2024 report from the Lancet Standing Commission on Dementia Prevention, Intervention, and Care brings promising developments for healthcare professionals and public health advocates. Newly included risk factors— untreated vision loss and high LDL cholesterol —underscore the critical role of these elements in maintaining cognitive health.

article thumbnail

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Known Heart Disease and Overweight or Obesity

DAIC

Getty Images milla1cf Fri, 03/08/2024 - 14:35 March 8, 2024 — Novo Nordisk today announced that the U.S. director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDA’s Center for Drug Evaluation and Research , in a statement issued by the FDA. Last accessed February 2024. 10,11 In the U.S.,

Obesity 111